Prevention of graft-versus-host disease

Clin Adv Hematol Oncol. 2012 Oct;10(10):663-5.
No abstract available

MeSH terms

  • Acute Disease
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers / blood
  • Chronic Disease
  • Graft vs Host Disease / immunology
  • Graft vs Host Disease / mortality
  • Graft vs Host Disease / pathology
  • Graft vs Host Disease / prevention & control*
  • Graft vs Leukemia Effect*
  • HLA Antigens / blood
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Leukemia / therapy
  • Lymphocyte Depletion
  • Lymphoma / therapy
  • Myelodysplastic Syndromes / therapy
  • Severity of Illness Index
  • Sex Factors
  • Stem Cell Transplantation*
  • Survival Rate
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology
  • T-Lymphocytes / pathology
  • Transplantation, Homologous
  • Unrelated Donors

Substances

  • Biomarkers
  • HLA Antigens
  • Immunosuppressive Agents